Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Children - The New York Times

The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic Covid-19.

About 6,900 children in the United States and Canada were enrolled in Modernas trial for those under 6. Moderna said there were no cases of severe illness, hospitalization or death. Most infections i… [+1545 chars]

full article...